Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2003
09/03/2003EP0929533B1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
09/03/2003CN1440390A Substituted diamide derivatives useful as motilin antagonists
09/03/2003CN1440389A Benzoylpyridine drivative or its salt, fungicide containing it as active ingredient, its production process and intermediate for producing it
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1440311A Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins
09/03/2003CN1120155C 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
09/03/2003CN1119988C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/02/2003US6613942 Glucagon antagonists/inverse agonists
09/02/2003US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages
09/02/2003US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
09/02/2003US6613909 Such as 5-bromo-2-iodopyridine; for production inhibitors in therapy for cytokine-mediated diseases (inflammatory and autoimmune diseases)
09/02/2003US6613805 For therapy and prophylaxis of neurodegenerative diseases such as Alzheimer's disease, Down's syndrome, Parkinson's disease, Creutzfeldt-Jacob disease, amyotrophic sclerosis on lateral fasciculus, multiple sclerosis, and neurological disorders
09/02/2003US6613804 Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
09/02/2003US6613803 Treating, preventing or ameliorating pain
09/02/2003US6613784 Cyclooxygenase inhibitors such as 2-acetyloxybenzoic acid 6-(nitroxymethyl)-2-methylpyridinyl ester hydrochloride, having good kinetics, solubility and efficiency; nontoxic
09/02/2003US6613783 Non-systemic control of parasites
09/02/2003US6613782 For treating and/or preventing endothelin dependent conditions, e.g. cardio- and cerebro-vascular disorders such as hypertension, vasoconstriction, congestive heart failure, cerebral disorders, respiratory system disorders
09/02/2003US6613769 Tryptase inhibitors
09/02/2003US6613764 Aspartic protease inhibitors
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
09/02/2003US6613572 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
09/02/2003US6613367 Complete nutrition of infants products are characterized by the type and amount of protein and carbohydrate and the increased levels of folic acid, vitamin B6 and vitamin B12 or their functional equivalents. These products improve feelings
09/02/2003US6613245 Crosslinkable liquid crystalline compounds
08/2003
08/28/2003WO2003071280A1 Fluorescent sensor for phosphate ion and phosphorylated peptide
08/28/2003WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003WO2003070693A1 Lactic acid derivative
08/28/2003WO2003070690A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003029217A3 Pyridinic sulfonamide derivatives, method of production and use thereof
08/28/2003WO2003027116A3 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
08/28/2003US20030163003 To form transition metal complexes which are used in such as asymmetric hydrogenation of imines, asymmetric hydride transfer reactions, hydrosilylation, hydroboration, hydrovinylation hydroformylation, allylic alkylation, etc.
08/28/2003US20030162974 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens
08/28/2003US20030162973 Reaction of the diazonium salt of an aminopyridine or aminobenzene in which the benzene ring bears one or more electron-withdrawing groups with a mixture of thionyl chloride in water, in the presence of an electron transfer-catalyst
08/28/2003US20030162967 Having antithrombotic effect; fortherapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses; reversible inhibitors of blood clotting enzymes factor Xa and/or factor VIIa
08/28/2003US20030162950 Coupling catalyst and process using the same
08/28/2003US20030162823 Novel C-4 substituted retinoids
08/28/2003US20030162817 Pentafluorobenzenesulfonamides and analogs
08/28/2003US20030162814 Amines such as 2-(3-(N-hydroxyamidino)phenylamino)-N-(2'-sulfamoylbiphenyl-4-yl)-2 -methylpropionamide, used as anticoagulants or for prophylaxis of arteriosclerosis, angina pectoris, restinosis or metastasis
08/28/2003US20030162799 Squaric acid derivatives
08/28/2003US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003US20030162765 Use in treatment and prevention of central nervous system and other disorders
08/28/2003US20030162759 Preventing or treating cardiovascular disease including atherosclerosis
08/28/2003US20030162724 Such as tris(4-(N-alpha-(2-(1H-indol-3-yl)acetyl)-L-lysyl)aminophenyl)methane hydrochloride for treatment of thrombocytopenia
08/28/2003US20030162690 Bood anticoagulant
08/28/2003CA2480002A1 Lactic acid derivative
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2474785A1 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/27/2003EP1337251A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/27/2003EP1337218A2 Substituted felbamate derived compounds
08/27/2003EP1185540B1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
08/27/2003EP1178042B1 Beta-diketonato-metal complexes and process for the preparation thereof, photoelectric conversion devices and photoelectrochemical cells
08/27/2003EP1165547B1 Substituted benzoylpyrazoles as herbicides
08/27/2003EP1007520B1 2-aminopyridines containing fused ring substituents as nos inhibitors
08/27/2003EP0901469B1 Arylalkylpiperazine compounds as antioxidants
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003EP0815084B1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1119321C Asymmetric synthesis of chiral beta-amino acids
08/27/2003CN1119149C 10,11 methanodibenzosuberane derivatives used as chemo sensitizing agents
08/26/2003US6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
08/26/2003US6610855 Synthesis of 3-amino-3-aryl propanoates
08/26/2003US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride
08/26/2003US6610853 N-(phenylsulfonyl)picolinamide derivatives, process for producing the same, and herbicide
08/26/2003US6610852 Prevent tissue damage; antidiabetic agents; Alzheimer's disease
08/26/2003US6610848 Platinum complex dioxygen sensors
08/26/2003US6610846 Heteroaromatic glucokinase activators
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610714 Non-nucleoside reverse transcriptase inhibitors
08/26/2003US6610701 For therapy and prophylaxis of blood coagulation and cardiovascular disorders
08/26/2003US6610700 Inhibit binding of integrins to their ligands, use in immune or inflammatory disorders; 3-(4-((2,6-Naphthyridinyl)amino)-phenyl)-2-((2-(1-ethylpropyl)-3-oxo-1 -cyclopentenyl) amino)-propionic acid, for example
08/26/2003US6610660 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates
08/26/2003US6610641 Transition metal complex
08/26/2003US6610324 Analgesics; rheumatic diseases; muscular disorders; sleep disorders
08/26/2003US6610284 Preparation for prevention and healing of inflammation affections
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2003068757A1 Novel pyridin- and pyrimidin-derivatives
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068746A1 Aryl ureas as kinase inhibitors
08/21/2003WO2003068745A1 Process for production of 2,3-diaminopyridine derivatives
08/21/2003WO2003068744A1 Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
08/21/2003WO2003068734A1 Carbamide esters for treating pain
08/21/2003WO2003068235A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068233A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068229A1 Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
08/21/2003WO2003068228A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003WO2003068183A1 Sunscreen compositions as well as dihydropyridines and dihydropyranes
08/21/2003WO2003047579B1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158419 Catalyzing the reaction of an aromatic compound with a Grignard reagent in presence of nickel chloride and N-methylimidazole; an intermediates for medicines, agricultural chemicals, liquid crystal materials
08/21/2003US20030158413 A thiochromane-7-carboxamide derivatives as Rho kinase enzyme inhibitor; nontoxic, anticancer agents
08/21/2003US20030158260 Halogenated N-phenyl-N'-benzoylurea derivatives for controlling a sea lice infestation on fish; e.g., 1-(4-chloro-3-(3-chloro-5-trifluoro-methyl-2-pyridyloxy)-phenyl)-3-(2,6 -difluorobenzoyl)urea
08/21/2003US20030158256 (Arylaminoaceamido)acetonitrile derivatives
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158235 Pyridine amido derivatives
1 ... 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 ... 633